Signaling Pathways - Thyroid Cancer - Renal Cell Carcinoma
清除全部
-
B2151 STF-62247Target: AutophagySummary: 肾细胞自噬诱导剂 -
B2295 Pirarubicin1 Citation中文名: 吡柔比星Target: TopoisomerasesSummary: 拓扑异构酶II抑制剂，蒽环类抗生素 -
B1510 Medroxyprogesterone acetate中文名: 醋酸甲羟孕酮Target: Progesterone ReceptorsSummary: 类固醇孕激素 -
B1564 Ranitidine中文名: 盐酸雷尼替丁Target: Histamine H2 ReceptorsSummary: 组胺H2受体拮抗剂 -
A8370 Axitinib (AG 013736)1 Citation中文名: 阿西替尼Target: VEGFR|PDGFR|c-KitSummary: VEGFR1/ c-Kit抑制剂 -
A8325 Tivantinib (ARQ 197)2 CitationTarget: METSummary: C-Met抑制剂 -
A2174 Lenvatinib (E7080)中文名: 乐伐替尼，仑伐替尼Target: VEGFR|PDGFR|RETSummary: VEGFR抑制剂 -
A2251 Tivozanib (AV-951)中文名: 替沃扎尼Target: VEGFRSummary: 有效的VEGFR选择性抑制剂 -
A8255 Sunitinib malate2 Citation中文名: 苹果酸舒尼替尼Target: VEGFRSummary: VEGFR/PDGFRβ/ KIT/ FLT3/RET/CSF-1R抑制剂 -
A3632 Motesanib中文名: 莫特塞尼Target: VEGFRSummary: Flk-1/Flt-4/PDGFR-/c-Kit抑制剂